Sutrasthana 1.43 — Chapters of the Cikitsasthana (Part 2)

"...prameha cikitsa (treatment of diabetes), vidradhi-vrddhi cikitsa (treatment of abscess and hernia), gulma cikitsa (treatment of abdominal tumour), udara cikitsa (treatment of enlargement of the abdomen), panduroga cikitsa (treatment of anaemia), svayathu cikitsa (treatment of dropsy), visarpa cikitsa (treatment of herpes), kustha cikitsa (treatment of leprosy and other skin disorders), svitra-krimi cikitsa (treatment of leucoderma and worms), vata-vyadhi cikitsa (treatment of diseases caused by vata-nervous diseases), vatasonita cikitsa (treatment of gout) — these twenty two chapters form the cikitsa sthana. 42-43½."

Translation: Prof. K.R. Srikantha Murthy, Ashtanga Hridayam Vol. I (Sutrasthana), Chowkhamba Krishnadas Academy, Varanasi.

Verse 43 completes the Cikitsāsthāna enumeration with treatment chapters for the remaining diseases, closing with the declaration: dvāviṃśaty adhyāyāḥ cikitsāsthānam — twenty-two chapters form the treatment section.

The diseases treated in this second group represent the chronic, complex, and often treatment-resistant conditions. Madhumeha cikitsā (treatment of diabetes) is particularly significant — diabetes is classified as one of the mahāroga (great diseases), and its treatment requires sustained, multi-modal intervention including dietary restriction (limiting sweet and heavy foods), herbal formulations that address the underlying meda (fat tissue) and kapha pathology, physical exercise, and specific Pañcakarma procedures. The Āyurvedic treatment of diabetes is not aimed at suppressing blood sugar — a concept the ancient physicians could not measure — but at correcting the metabolic dysfunction that produces it.

Kuṣṭha cikitsā (treatment of skin diseases) and visarpa cikitsā (treatment of erysipelas/spreading skin disease) address conditions where the doṣas manifest on the surface of the body. Visarpa — literally "spreading" — describes conditions where inflammation spreads rapidly across the skin, corresponding to modern erysipelas, cellulitis, or herpes zoster. The treatment distinguishes between eka-doṣa (single-doṣa) and sannipāta (multi-doṣa) presentations, modifying the protocol accordingly.

Gulma-udara cikitsā combines the treatment of abdominal masses (gulma) and abdominal distension/ascites (udara) — conditions that share the clinical feature of abdominal enlargement but differ in pathogenesis. Pāṇḍuroga cikitsā (treatment of anemia/pallor) focuses on restoring the function of rañjaka pitta and building the rakta (blood) dhātu through iron-rich preparations, liver-supporting herbs, and blood-nourishing dietary protocols.

The appearance of viṣamajvara cikitsā (treatment of intermittent fevers) — distinct from the general jvara cikitsā in verse 42 — is noteworthy. Intermittent fevers with periodic recurrence correspond to what modern medicine recognizes as malaria and other cyclical febrile illnesses. The Āyurvedic tradition recognized the periodicity of certain fevers — quotidian, tertian, quartan — and prescribed specific treatments based on the cycle length and doṣic pattern, a clinical sophistication that parallels the Greek Hippocratic tradition's observations about malarial periodicity.

The Cikitsāsthāna closes, like the Nidānasthāna, with vātavyādhi cikitsā (treatment of vāta diseases) and vātaśoṇita cikitsā (treatment of gout). The treatment of vāta diseases is the most therapeutically challenging section of the Cikitsāsthāna because vāta's variable, mobile nature produces conditions that resist standardized protocols. The treatment requires continuous adjustment — the physician must monitor the patient's response and modify the formulation, dietary protocol, and procedural approach based on how the condition evolves. This adaptive treatment style — what modern medicine calls "treat to target" — is the hallmark of advanced Āyurvedic clinical practice.

The treatment of chronic and complex diseases — diabetes, skin diseases, abdominal masses, intermittent fevers — represents the clinical frontier of every medical tradition. The approaches reveal each tradition's therapeutic philosophy.

The Āyurvedic treatment of madhumeha (diabetes) through dietary restriction, exercise, and metabolic correction parallels modern functional medicine's approach to type 2 diabetes — lifestyle modification as first-line treatment before pharmaceutical intervention. The convergence is not coincidental: both traditions recognize that metabolic diseases arise from metabolic causes and respond best to metabolic corrections.

In Traditional Chinese Medicine, the treatment of xiāo kě (wasting-thirst/diabetes) employs herbal formulations that address the spleen-kidney axis — strengthening the spleen's transformative capacity and nourishing kidney yin. The Āyurvedic approach targets meda dhātu (fat tissue) and kapha aggravation through a different physiological framework, but both traditions share the recognition that diabetes is a systemic metabolic disorder requiring systemic metabolic treatment, not symptomatic suppression.

The treatment of intermittent fevers has a particularly interesting cross-traditional history. The Āyurvedic recognition of periodic fever patterns parallels the Hippocratic tradition's classification of tertian and quartan fevers — classifications that remained central to European medicine until the malarial parasite was identified in the 19th century. The Chinese herbal treatment of malaria with qīng hāo (Artemisia annua) — which led to the 2015 Nobel Prize for Tu Youyou — represents a case where traditional pharmacological knowledge validated by modern science points to a depth of empirical observation in ancient medical systems.

The Unani treatment approach — which classifies therapies into regimenal (tadbīr), dietary (ghidhā), pharmacological (dawā), and surgical (yad) — parallels the Āyurvedic Cikitsāsthāna's use of multiple treatment modalities within each chapter. Both traditions recognize that complex diseases require multi-modal treatment, not single interventions.

The Cikitsāsthāna's twenty-two chapters, now fully enumerated, teach a principle about the nature of treatment itself: effective treatment requires matching the intervention to the mechanism, not the label.

Two patients with "diabetes" may have completely different doṣic mechanisms — one driven primarily by kapha (obesity, lethargy, excessive sweetness) and another by vāta (wasting, instability, erratic digestion). The treatment differs. Two people with the same named problem — in health, work, or relationship — may have completely different underlying dynamics. The intervention that works for one may harm the other. The Cikitsāsthāna teaches the physician to look past the disease name to the mechanism beneath it, and to construct the treatment from the mechanism rather than from the name.

The closing of both the diagnostic and treatment sections with vāta diseases reinforces a universal truth: the hardest problems require the most adaptive solutions. Vāta diseases resist standardized protocols because vāta itself is variable. The treatment must be as flexible as the condition — adjusting day by day, responding to the patient's evolving presentation, never locking into a fixed protocol when the disease refuses to stay fixed. This adaptive capacity — the willingness to observe, adjust, and respond rather than rigidly following a plan — is the mark of clinical mastery in any field.

The treatment chapters enumerated here address conditions that represent some of the greatest challenges in modern clinical practice: diabetes, chronic skin diseases, autoimmune-mediated inflammation, anemia, and chronic neurological conditions.

The Āyurvedic approach to these conditions offers something that modern pharmaceutical treatment often lacks: a framework for understanding why the disease arose and how to address the cause rather than suppress the symptom. Modern diabetes treatment focuses on blood sugar control through medication. Āyurvedic diabetes treatment focuses on correcting the metabolic dysfunction — the impaired meda (fat tissue) metabolism, the weakened agni, the accumulated āma — that produces the elevated blood sugar. Both approaches are valid; the Āyurvedic framework adds a causal depth that the pharmaceutical approach does not address.

The treatment of pāṇḍuroga (anemia) is practically applicable today. The Āyurvedic protocol includes iron-rich preparations (like loha bhasma — calcined iron), liver-supporting herbs (like kalamegha / Andrographis and bhumyamalaki / Phyllanthus), and blood-building foods (pomegranate, beet, dark leafy greens, black sesame, jaggery). The dietary recommendations for anemia can be implemented immediately alongside any conventional treatment.

For personal application: the Cikitsāsthāna's most transferable principle is the insistence on treating the mechanism rather than the symptom. Before reaching for a remedy — over-the-counter, herbal, or prescribed — ask: what is the mechanism? Is this a condition of excess or deficiency? Of heat or cold? Of dryness or dampness? Of mobility or stagnation? The answer determines the treatment direction. This simple assessment — which doṣa, which quality, which direction — prevents the common error of applying a treatment that addresses the symptom while aggravating the cause.